Additionally, strategies of combined therapies of natural bioactive compounds and antidiabetic drugs, including their combinations with insulin [8, 9] or metformin [10–12], have been proposed recently in an attempt to improve the glycemic control, decrease dyslipidemia, and mitigate the diabetic complications related to oxidative stress. This evidence concerns the gene INS and metabolic syndrome.